| Canis lupus familiaris |
Canis familiaris |
Activity |
-27.0 |
% |
10.1021/jm800830n |
| Canis lupus familiaris |
Canis familiaris |
Activity |
-22.0 |
% |
10.1021/jm800830n |
| Canis lupus familiaris |
Canis familiaris |
Activity |
30.0 |
% |
10.1021/jm800830n |
| Canis lupus familiaris |
Canis familiaris |
CL |
36.0 |
mL.min-1.kg-1 |
10.1021/jm991030j |
| Canis lupus familiaris |
Canis familiaris |
Clearance |
6.2 |
ul min-1 |
10.1021/jm991030j |
| Homo sapiens |
A2780 |
IC50 |
24230.0 |
nM |
10.1016/j.bmcl.2013.10.049 |
| Homo sapiens |
A549 |
Activity |
9.6 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
9.6 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
10.0 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
10.0 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
10.9 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
10.9 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
11.2 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
11.2 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
12.0 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
12.0 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
13.4 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
13.4 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
66.1 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
66.1 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Activity |
66.8 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
Activity |
66.8 |
% |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
IC50 |
24800.0 |
nM |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
A549 |
IC50 |
24900.0 |
nM |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
A549 |
IC50 |
31400.0 |
nM |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
A549 |
Ratio IC50 |
2.0 |
None |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
14316.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
1580.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
25894.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
23428.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-synuclein |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
16353.5 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
18348.9 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
25000.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.87 |
None |
10.1016/j.bmc.2009.08.022 |
| Homo sapiens |
Caco-2 |
logPapp |
-4.87 |
None |
10.1016/j.bmc.2011.03.011 |
| Homo sapiens |
Calcium release-activated calcium channel protein 1 |
IC50 |
52100.0 |
nM |
10.1016/j.bmc.2016.11.007 |
| Homo sapiens |
Calcium release-activated calcium channel protein 1 |
IC50 |
100000.0 |
nM |
10.1016/j.bmc.2016.11.007 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
4256.2 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
31622.78 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
50000.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
1320.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
28400.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
316.23 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
63.0 |
nM |
10.1016/j.bmcl.2012.10.140 |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
840.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2J2 |
IC50 |
2140.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
316.23 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
130.0 |
nM |
10.1021/jm021012t |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
300.0 |
nM |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
470.0 |
nM |
10.1124/dmd.112.048264 |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
140000.0 |
nM |
10.1016/j.bmcl.2015.07.038 |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
20.0 |
% |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
80.0 |
% |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
280.0 |
nM |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
2300.0 |
nM |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 3A4 |
Kinact |
0.4 |
/min |
10.1021/jm300065h |
| Homo sapiens |
Cytochrome P450 3A4 |
Kinact |
0.59 |
/min |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ks |
0.69 |
uM |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
mechanism based inhibition |
nan |
None |
10.2174/138920005774330639 |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
PPB |
nan |
% |
10.1124/dmd.111.038505 |
| Homo sapiens |
Cytochrome P450 3A4 |
Ratio |
2143.0 |
ml/min/umol |
10.1124/dmd.111.038505 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10070.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
825.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
9531.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
5972.8 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HCT-116 |
IC50 |
nan |
None |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
HEK293 |
Potency |
5171.4 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
1506.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
580.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
HERG |
IC50 |
806.0 |
nM |
10.1021/jm800830n |
| Homo sapiens |
HERG |
IC50 |
1300.0 |
nM |
10.1016/j.bmcl.2015.07.038 |
| Homo sapiens |
HERG |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2011.07.087 |
| Homo sapiens |
HERG |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2019.03.026 |
| Homo sapiens |
HERG |
IC50 |
1400.0 |
nM |
10.1016/j.bmcl.2004.06.070 |
| Homo sapiens |
HERG |
IC50 |
1400.0 |
nM |
10.1016/j.bmcl.2010.03.084 |
| Homo sapiens |
HERG |
IC50 |
1400.0 |
nM |
10.1016/j.bmcl.2010.11.033 |
| Homo sapiens |
HERG |
IC50 |
1400.0 |
nM |
10.1016/j.bmcl.2012.12.072 |
| Homo sapiens |
HERG |
IC50 |
1430.0 |
nM |
10.1021/jm0208875 |
| Homo sapiens |
HERG |
IC50 |
1445.44 |
nM |
10.1016/j.bmc.2008.04.028 |
| Homo sapiens |
HERG |
IC50 |
1445.44 |
nM |
10.1016/j.bmcl.2005.01.008 |
| Homo sapiens |
HERG |
IC50 |
1445.44 |
nM |
10.1016/j.bmcl.2005.03.080 |
| Homo sapiens |
HERG |
IC50 |
1445.44 |
nM |
10.1016/j.ejmech.2008.11.009 |
| Homo sapiens |
HERG |
IC50 |
1445.44 |
nM |
10.1016/s0960-894x(03)00492-x |
| Homo sapiens |
HERG |
IC50 |
1800.0 |
nM |
10.1093/cvr/cvr044 |
| Homo sapiens |
HERG |
IC50 |
3300.0 |
nM |
10.1016/j.bmcl.2012.10.140 |
| Homo sapiens |
HERG |
Ki |
190.0 |
nM |
10.1021/jm0700565 |
| Homo sapiens |
HERG |
Ki |
353.0 |
nM |
10.1021/jm0700565 |
| Homo sapiens |
HERG |
Ratio Ki |
1.85 |
None |
10.1021/jm0700565 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-10.9 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
3.41 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
Homo sapiens |
Activity |
0.69 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
CL |
7.0 |
mL.min-1.kg-1 |
10.1021/jm991030j |
| Homo sapiens |
Homo sapiens |
Clearance |
0.9 |
ul min-1 |
10.1021/jm991030j |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Liver microsome |
Stability |
43.0 |
% |
10.1016/j.bmcl.2014.06.026 |
| Homo sapiens |
Liver microsome |
Stability |
64.0 |
% |
10.1021/ml500187a |
| Homo sapiens |
Liver microsomes |
CL |
56.5 |
mL.min-1.g-1 |
10.1016/j.bmcl.2012.10.140 |
| Homo sapiens |
Liver microsomes |
Drug metabolism |
nan |
None |
10.1016/j.bmcl.2012.10.140 |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
979.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
17726.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
3848.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
58047.9 |
nM |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
20214.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
32642.7 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
8.9 |
nM/mg*min |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
60.0 |
% |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2004.01.156 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1200.0 |
nM |
10.1124/mol.61.5.964 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1500.0 |
nM |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1600.0 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
1800.0 |
nM |
10.1021/jm021012t |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
60.0 |
% |
10.1021/jm021012t |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
73078.0 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
10399.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
13091.8 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
18492.7 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
746.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
22786.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SH-SY5Y |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
IC50 |
20540.0 |
nM |
10.1016/j.bmcl.2013.10.049 |
| Homo sapiens |
Sodium channel alpha subunit |
IC50 |
980.0 |
nM |
10.1093/cvr/cvr044 |
| Homo sapiens |
Sodium channel protein type IX alpha subunit |
IC50 |
500.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
880.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
IC50 |
500.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Activity |
56.4 |
% |
10.1021/jm070524a |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombopoietin |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
21860.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel |
IC50 |
156.0 |
nM |
10.1093/cvr/cvr044 |
| Homo sapiens |
Voltage-gated L-type calcium channel |
IC50 |
510.0 |
nM |
10.1038/srep02100 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
47999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
202.0 |
nM |
10.1016/j.bmcl.2015.07.038 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
250.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
108000.0 |
nM |
10.1002/jat.2784 |
| Homo sapiens |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
288000.0 |
nM |
10.1002/jat.2784 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
IC50 |
416.0 |
nM |
10.1016/j.bmcl.2010.09.098 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2010.03.084 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
Inhibition |
57.4 |
% |
10.1016/j.bmcl.2006.05.031 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
Inhibition |
67.6 |
% |
10.1016/j.bmcl.2004.10.078 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
Inhibition |
67.6 |
% |
10.1016/j.bmcl.2006.10.024 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
Inhibition |
67.6 |
% |
10.1016/j.bmcl.2007.08.070 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
Inhibition |
67.63 |
% |
10.1016/j.bmc.2010.06.082 |
| Homo sapiens |
Voltage-gated N-type calcium channel alpha-1B subunit |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.11.007 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
64.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
200.0 |
nM |
10.1016/j.bmc.2011.07.030 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
560.0 |
nM |
10.1016/j.bmcl.2013.10.049 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
560.0 |
nM |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
830.0 |
nM |
10.1016/j.bmcl.2010.05.030 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
830.0 |
nM |
10.1016/j.bmcl.2012.12.072 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
840.0 |
nM |
10.1016/j.bmc.2006.10.013 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
840.0 |
nM |
10.1016/j.bmcl.2004.04.090 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
860.0 |
nM |
10.1016/j.bmcl.2010.05.030 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2010.06.082 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmc.2006.11.004 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmc.2010.06.082 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2004.10.078 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2006.05.031 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2006.10.024 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2006.10.042 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2007.08.070 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2008.06.037 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2010.03.084 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2010.11.033 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1340.0 |
nM |
10.1016/j.bmcl.2015.12.010 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
IC50 |
1430.0 |
nM |
10.1016/j.bmc.2006.09.051 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
55.1 |
% |
10.1016/j.bmcl.2013.10.049 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
55.1 |
% |
10.1016/j.bmcl.2014.01.071 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
77.6 |
% |
10.1016/j.bmcl.2007.08.070 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
78.17 |
% |
10.1016/j.bmc.2006.11.004 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
78.92 |
% |
10.1016/j.bmcl.2010.03.084 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
78.92 |
% |
10.1016/j.bmcl.2010.11.033 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
78.95 |
% |
10.1016/j.bmcl.2011.07.087 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
79.2 |
% |
10.1016/j.bmc.2016.06.006 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
80.0 |
% |
10.1016/j.bmcl.2010.05.030 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
81.0 |
% |
10.1016/j.bmcl.2012.12.072 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
81.0 |
% |
10.1016/j.bmcl.2019.03.026 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
89.8 |
% |
10.1016/j.bmcl.2006.05.031 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmc.2006.11.004 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmcl.2004.04.090 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmcl.2004.10.078 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmcl.2006.10.024 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmcl.2007.08.070 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1G subunit |
Inhibition |
95.9 |
% |
10.1016/j.bmcl.2008.06.037 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
32.0 |
nM |
10.1016/j.bmcl.2010.09.098 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
130.0 |
nM |
10.1016/j.bmcl.2007.11.103 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
130.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
181.0 |
nM |
10.1016/j.bmcl.2015.07.038 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2010.06.082 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
1000.0 |
nM |
10.1016/j.bmcl.2012.10.140 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
IC50 |
nan |
None |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
76.0 |
% |
10.1016/j.bmc.2016.06.006 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
76.0 |
% |
10.1016/j.bmcl.2019.03.026 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
86.0 |
% |
10.1016/j.bmc.2006.11.004 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
86.0 |
% |
10.1016/j.bmcl.2004.04.090 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
86.0 |
% |
10.1016/j.bmcl.2004.10.078 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
86.0 |
% |
10.1016/j.bmcl.2006.05.031 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
86.0 |
% |
10.1016/j.bmcl.2006.10.024 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1H subunit |
Inhibition |
nan |
% |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1I subunit |
IC50 |
126.0 |
nM |
10.1021/jm800830n |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1I subunit |
IC50 |
130.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1I subunit |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2010.06.082 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1I subunit |
IC50 |
nan |
None |
10.1016/j.bmc.2020.115491 |
| Homo sapiens |
Voltage-gated T-type calcium channel alpha-1I subunit |
Inhibition |
nan |
% |
10.1016/j.bmc.2020.115491 |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Mus musculus |
P-glycoprotein 1 |
IC50 |
10000.0 |
nM |
10.1021/jm021012t |
| Mus musculus |
P-glycoprotein 3 |
IC50 |
7400.0 |
nM |
10.1021/jm021012t |
| Mus musculus |
P-glycoprotein 3 |
Ratio |
1.3 |
None |
10.1021/jm021012t |
| Mus musculus |
P-glycoprotein 3 |
Ratio |
2.7 |
None |
10.1021/jm021012t |
| Mus musculus |
P-glycoprotein 3 |
Ratio |
3.5 |
None |
10.1021/jm021012t |
| Plasmodium yoelii yoelii |
Plasmodium yoelii yoelii |
IC50 |
0.873 |
nM |
10.1021/jm201095h |
| Plasmodium yoelii yoelii |
Plasmodium yoelii yoelii |
IC50 |
0.873 |
nM |
10.1128/aac.01043-07 |
| Rattus norvegicus |
Cacna1b/Cacnb3 |
IC50 |
1000.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Heart |
EC50 |
26.0 |
nM |
10.1016/j.bmcl.2015.07.038 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
17782.8 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
35481.3 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
ABC |
437.0 |
mmHg.hr |
10.1016/j.bmcl.2015.07.038 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
32.0 |
mmHg |
10.1016/j.bmcl.2015.07.038 |
| Rattus norvegicus |
Rattus norvegicus |
CL |
94.0 |
mL.min-1.kg-1 |
10.1021/jm991030j |
| Rattus norvegicus |
Rattus norvegicus |
Clearance |
5.4 |
ul min-1 |
10.1021/jm991030j |
| Rattus norvegicus |
Sodium channel protein type II alpha subunit |
IC50 |
500.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Rattus norvegicus |
Sodium channel protein type IV alpha subunit |
IC50 |
500.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
354.8 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
501.2 |
nM |
None |
| Rattus norvegicus |
Transient receptor potential cation channel subfamily M member 8 |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.11.007 |
| Rattus norvegicus |
Vanilloid receptor |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.11.007 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel |
IC50 |
7000.0 |
nM |
10.1016/j.bmcl.2007.11.103 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
IC50 |
1100.0 |
nM |
None |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
16360.1 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-6.34 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.43 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.2948 |
None |
10.1101/2020.04.03.023846 |
| None |
ADMET |
CL |
4.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
delta logD |
-0.9 |
None |
10.1021/jm0000564 |
| None |
ADMET |
EFTPC |
9.0 |
nM |
10.1093/cvr/cvr044 |
| None |
ADMET |
F |
79.0 |
% |
10.1021/jm0000564 |
| None |
ADMET |
log10(%HIA +10) |
1.898 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
logPapp |
-4.87 |
None |
10.1124/dmd.111.041665 |
| None |
ADMET |
MRT |
13.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Stability |
nan |
% |
10.1016/j.bmcl.2019.03.026 |
| None |
ADMET |
T1/2 |
13.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
3.1 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatocyte |
TC50 |
6.79 |
10'4nM |
10.1128/aac.01043-07 |
| None |
Hepatotoxicity |
DILI positive/negative |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
NON-PROTEIN TARGET |
EC30 |
2.9 |
uM |
10.1016/j.bmc.2011.07.030 |
| None |
NON-PROTEIN TARGET |
Fu |
0.005 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
IC50 |
18400.0 |
nM |
10.1016/j.bmcl.2014.01.071 |
| None |
NON-PROTEIN TARGET |
IC50 |
35260.0 |
nM |
10.1016/j.bmcl.2013.10.049 |
| None |
NON-PROTEIN TARGET |
MPE |
17.29 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
25.25 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
34.77 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
41.44 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
41.76 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
43.19 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
57.37 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
63.33 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
72.78 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
92.23 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
145.05 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
NON-PROTEIN TARGET |
MPE |
156.75 |
% |
10.1016/j.ejmech.2016.07.032 |
| None |
No relevant target |
LogD |
1.25 |
None |
10.1021/jm0000564 |
| None |
No relevant target |
LogD |
1.96 |
None |
10.1016/j.ejmech.2008.11.009 |
| None |
No relevant target |
LogD |
3.66 |
None |
10.1124/dmd.111.041665 |
| None |
No relevant target |
LogP |
3.86 |
None |
10.1021/jm070524a |
| None |
No relevant target |
LogP |
6.2 |
None |
10.1021/jm021012t |
| None |
No relevant target |
pKa |
9.3 |
None |
10.1021/jm0000564 |
| None |
Unchecked |
IC50 |
7.0 |
nM |
10.1021/jm800830n |
| None |
Unchecked |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2018.07.023 |
| None |
Unchecked |
IC50 |
1000.0 |
nM |
10.1021/acs.jmedchem.7b01236 |
| None |
Unchecked |
IC50 |
4320.0 |
nM |
10.1021/acs.jmedchem.8b00035 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2010.06.082 |
| None |
Unchecked |
Potency |
1412.5 |
nM |
None |
| None |
Unchecked |
Potency |
4466.8 |
nM |
None |
| None |
Unchecked |
Potency |
7304.8 |
nM |
None |
| None |
Unchecked |
Potency |
8912.5 |
nM |
None |
| None |
Unchecked |
Potency |
19952.6 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Ratio |
1.4 |
None |
10.1016/j.bmcl.2006.10.024 |
| None |
Unchecked |
Ratio |
1.6 |
None |
10.1016/j.bmcl.2006.05.031 |
| None |
Unchecked |
Ratio IC50 |
1.69 |
None |
10.1016/j.bmcl.2012.12.072 |
| None |
Unchecked |
Ratio IC50 |
13.0 |
None |
10.1016/j.bmcl.2010.09.098 |
| None |
Unchecked |
Selectivity |
1.4 |
None |
10.1016/j.bmcl.2004.10.078 |
| None |
Unchecked |
Selectivity Index |
77000.0 |
None |
10.1128/aac.01043-07 |
| None |
Unchecked |
Selectivity ratio |
1.4 |
None |
10.1016/j.bmcl.2007.08.070 |
| None |
Unchecked |
Selectivity ratio |
10.0 |
None |
10.1021/jm800830n |